Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Americans see hair transplants as valuable for treating hair loss and want them to be more affordable and tailored to each gender.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Minoxidil alone is the most cost-effective treatment for male hair loss at a $50,000 threshold.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Organizations help patients access discounts for expensive dermatology medications.

Scalp cooling is cost-effective for reducing hair loss from chemotherapy and should be covered by insurance.

Rebamipide may help regrow hair by activating hair follicle stem cells.

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Redefining drug dosages is crucial when repurposing them for new uses.

Lenders play a big role in financing assisted reproduction and adoption.

Insurers opposed ASCO's recommendation for a single cancer care pathway program.

Doctors should prescribe cheaper, off-label medication and teach patients how to use it to save money ethically.

Burn reconstruction is crucial for improving long-term outcomes for burn survivors.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.